During the past decade, Neuropsychiatric Research Institute conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Neuropsychiatric Research Institute" #1 sponsor was "Neuropsychiatric Research Institute, Fargo, North Dakota" with 7 trials, followed by "North Dakota State University" with 6 trials sponsored, "University of Pittsburgh" with 2 trials sponsored, "Shire" with 1 trials sponsored and "University of Minnesota" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Neuropsychiatric Research Institute" #1 collaborator was "Neuropsychiatric Research Institute, Fargo, North Dakota" with 5 trials as a collaborator, "University of North Dakota" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 2 trials as a collaborator and "Columbia University" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Neuropsychiatric Research Institute" are "Obesity" (4 trials), "Bariatric Surgery Candidate" (2 trials), "Binge Eating Disorder" (2 trials), "Eating Disorders" (2 trials) and "Roux en Y Gastric Bypass" (2 trials). Many other conditions were trialed in "Neuropsychiatric Research Institute" in a lesser frequency.

Most popular intervention types in "Neuropsychiatric Research Institute" are "Drug" (8 trials), "Other" (3 trials), "Behavioral" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Alcohol" (1 trials), "Bupropion SR and XL" (1 trials), "CBT" (1 trials), "CBT-Guided Self Help" (1 trials) and "Duloxetine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neuropsychiatric Research Institute" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Neuropsychiatric Research Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Neuropsychiatric Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Neuropsychiatric Research Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 4 trials that are defined as “Not Applicable".